The UNM Gastroenterology and Hepatology Fellowship Program provides education and mentorship in both clinical practice and research. Read moreApplications are accepted only through the"Electronic Residency Application Service (ERAS). 

Division of Gastroenterology and Hepatology
Department of Internal Medicine
1 University of New Mexico
Albuquerque, New Mexico 87131
Phone: (505) 272-4961

Clinical services:

UNM Health System Patient Care
Appointments: (505) 272-2530

Gastroenterology and Hepatology Research

Project Echo LogoProject Extension for Community Healthcare Outcomes (Project ECHO) is a telemedicine and distance-learning program designed to improve access to quality health care for New Mexicans with hepatitis C. Project ECHO links health-care providers from rural clinics, the Indian Health Service, and prisons with specialists at the University of New Mexico.

At weekly clinics, partners present and discuss patients with hepatitis C with specialists. Partners can receive continuing education credits for participating. Since June 2003, 173 hepatitis C clinics have been conducted with 1,843 case presentations. Partners have received 390 hours of training and 2,997 hours of continuing education credits. And in 2006, the State Legislature approved $1.5 million in annual funding for the project. Project ECHO has increased access to state-of-the art hepatitis C virus care for patients living in rural areas or prisons. Because of its success with hepatitis C, this project is being expanded to other chronic medical conditions. For more information, visit the Project ECHO website.

Principal Investigator

Edgar Boedeker, MD

Edgar Boedeker
  • Professor of Medicine, UNM
  • Staff physician in Gastroenterology,
    New Mexico VA Medical Center
  • Attending gastroenterologist,
    University of New Mexico
  • Publications and CV

Boedeker Research Lab

Dr. Boedeker directs a basic laboratory, based at the Albuquerque VA Medical Center, focused on elucidating the molecular pathogenesis of important intestinal infections, primarily those caused by virulent strains of Escherichia coli. His laboratory uses its knowledge of pathogenesis to develop vaccines directed against such virulent forms of Escherichia coli as the shiga toxin producing (STEC) strains causing hemorrhagic colitis, and the enterotoxigenic (ETEC) strains causing Traveler's and infantile diarrhea. Recent funded work in his laboratory has demonstrated a role for Zinc in the specific treatment of STEC infections. He also studies the interplay of the intestinal microbiota and specific infectious agents in inflammatory bowel disease. He has continually served on number of national scientific review committees overseeing funding of research in gastroenterology and infectious diseases. Member, NIH study section.

Research Focus

  • Molecular pathogenesis of enteric Esherichia coli infections.
  • Enteric vaccine development.
  • Microbiome and infectious agents in inflammatory bowel disease.

Principal Investigator

Henry C Lin, MD

Henry Lin
  • Tenured Professor of Medicine
  • Chief of the Section of Gastroenterology NMVAHCS
  • Associate Chief of Medicine NMVAHCS
  • Director, UNM GI Motility Program
  • Publications and CV

Lin Research Lab

The Lin research laboratory, based at the Albuquerque VA Medical Center,  specializes in the treatment of irritable bowel syndrome and other functional disorders and is a recognized international leader in the role of gut bacteria in these conditions. Dr. Lin heads an innovative bench-to-bedside translational research program in host-gut bacterial interactions at NMVAHCS and UNM, and serves on national scientific committees overseeing the research in gastroenterology.

Research Focus

  • Investigate the role of bacterial overgrowth in functional disorders
  • Investigate the interaction of diet and gut microbiota